EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ATF4/MYC Regulates MTHFD2 to Promote NSCLC Progression by Mediating Redox Homeostasis

Yixing Gao, Lan Feng, Luping Zhang, Jianhui Geng, Erlong Zhang iD

Disease Markers · 22.08.2022 · 2022 · 1-16

DOI: 10.1155/2022/7527996 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Markers, erschienen am 22.08.2022. Verfasst von Yixing Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Xinqiao Hospital, Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Activating Transcription Factor 4, Aminohydrolases, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) has been reported to be overexpressed in non-small-cell lung cancer (NSCLC) and to correlate with malignant proliferation. However, the mechanism of high MTHFD2 expression in NSCLC has not been clarified. Methods. qPCR, western blot, and immunofluorescence experiments were used to measure the expression of related mRNAs and proteins. Cell apoptosis was measured by flow cytometry and TUNEL assays. The CCK-8 assay was used to determine cell viability. Flow cytometry was used to analyze the cell cycle. ROS, H2O2, MDA, SOD, and NADPH/NADP+ were evaluated by relevant assay kits. Transfection of siRNA or vectors was used to downregulate or upregulate gene expression. Dual-luciferase reporter gene assays were used to evaluate the regulated relationship between MTHFD2 and ATF4 or MYC.

Results

MTHFD2 was highly expressed in NSCLC cells. Knockdown of MTHFD2 inhibited proliferation and increased apoptosis. Furthermore, oxidative factors significantly increased, while antioxidant factors significantly decreased in NSCLC cells with MTHFD2 knockdown, indicating that MTHFD2 was involved in NSCLC progression through the redox pathway. Although MTHFD2 was downregulated with ATF4 silencing, the dual-luciferase reporter assay suggested that ATF4 did not directly mediate MTHFD2 transcription. Further studies revealed that MYC had a transcriptional effect on MTHFD2 and was also regulated by ATF4. PCR, and western blotting experiments with ATF4 knockdown and MYC overexpression as well as ATF4 overexpression and MYC knockdown proved that ATF4 stimulated MTHFD2 through MYC mediation.

Conclusions

ATF4 promoted high expression of MTHFD2 in NSCLC dependent on MYC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Activating Transcription Factor 4AminohydrolasesCarcinoma, Non-Small-Cell LungLung NeoplasmsMethylenetetrahydrofolate Dehydrogenase (NADP)Multifunctional EnzymesProto-Oncogene Proteins c-mycApoptosisCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticHomeostasisHumansHydrogen PeroxideLuciferasesOxidation-Reduction

Substanzen

ATF4 protein, humanMTHFD2 protein, humanMYC protein, humanMultifunctional EnzymesProto-Oncogene Proteins c-mycActivating Transcription Factor 4Hydrogen PeroxideLuciferasesMethylenetetrahydrofolate Dehydrogenase (NADP)Aminohydrolases

Autor:innen und Institutionen

  • Department of Oncology, Xinqiao Hospital, Army Medical University, Chongqing, China.
  • Key Laboratory of Immunotherapy, Xinqiao Hospital, Army Military Medical University, Chongqing, China.
  • Institute of Medicine and Equipment for High Altitude Region, College of High Altitude Military Medicine, Army Medical University, Chongqing, China.
  • Key Laboratory of Extreme Environmental Medicine, Ministry of Education of China, Chongqing, China.
  • Key Laboratory of High Altitude Medicine, People's Liberation Army, Chongqing, China.
  • State Key Laboratory of Ultrasound in Medicine and Engineering, Chongqing Medical University, Chongqing, China.

ORCID-Profile: Erlong Zhang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Gao, Y., Feng, L., Zhang, L., Geng, J., & Zhang, E. (2022). ATF4/MYC Regulates MTHFD2 to Promote NSCLC Progression by Mediating Redox Homeostasis. Disease Markers, 2022, 1-16. https://doi.org/10.1155/2022/7527996

Vancouver

Gao Y, Feng L, Zhang L, Geng J, Zhang E. ATF4/MYC Regulates MTHFD2 to Promote NSCLC Progression by Mediating Redox Homeostasis. Disease Markers. 2022;2022:1-16. doi:10.1155/2022/7527996

BibTeX
@article{Gao2022,
  author = {Gao, Yixing and Feng, Lan and Zhang, Luping and Geng, Jianhui and Zhang, Erlong},
  title = {ATF4/MYC Regulates MTHFD2 to Promote NSCLC Progression by Mediating Redox Homeostasis},
  journal = {Disease Markers},
  year = {2022},
  volume = {2022},
  pages = {1--16},
  doi = {10.1155/2022/7527996}
}
Kostenlos starten →